BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32372513)

  • 1. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
    Mu Y; Xie F; Sun T
    J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
    Ren Z; Ding HM; Qian X; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
    [No Abstract]   [Full Text] [Related]  

  • 3. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
    Chen P; Lu W; Chen T
    J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application Value Analysis of Seven-Autoantibody Panel in the Lung Cancer Screening in Yunnan.
    Li W; Sun Y; Xu N
    Comput Intell Neurosci; 2022; 2022():2368155. PubMed ID: 35832243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
    Mu Y; Li J; Xie F; Xu L; Xu G
    J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic efficiency of seven autoantibodies in lung cancer.
    Huang H; Luo W; Ni Y; Sun S; Wang C; Zhang L
    Eur J Cancer Prev; 2020 Jul; 29(4):315-320. PubMed ID: 31764214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of seven autoantibodies in lung cancer diagnosis.
    Luo B; Mao G; Ma H; Chen S
    J Thorac Dis; 2021 Jun; 13(6):3660-3668. PubMed ID: 34277058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
    Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
    PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
    Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
    Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of autoantibody detection in the diagnosis and staging of lung cancer.
    Wang Y; Jiao Y; Ding CM; Sun WZ
    Ann Transl Med; 2021 Nov; 9(22):1673. PubMed ID: 34988182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
    Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
    Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance Evaluation of an Enzyme-Linked Immunosorbent Assay for Seven Autoantibodies in Lung Cancer.
    Yin-Yu M; Fu-Yi X; Fei-Bo W; Ri-Yi Z; Xiao-Lin Y
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
    Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
    Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
    Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients].
    Ma L; Yue W; Zhang L; Wang Y; Zhang C; Yang X
    Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):706-12. PubMed ID: 20673487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
    Liu X; Shen Q; Wen Y; Jiang Z; Ma Z; Zeng P; He J; Liao Y; Huang Y; Huang J
    Am J Clin Oncol; 2024 Apr; 47(4):149-154. PubMed ID: 38054473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules.
    Ling Z; Chen J; Wen Z; Wei X; Su R; Tang Z; Hu Z
    Dis Markers; 2021; 2021():6677823. PubMed ID: 33688380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.